Supported By: Sanofi and Regeneron
Exhibit Hall, Learning Theater 1
Boston Convention and Exhibition Center

Program Description

Join Dr. Nicola Hanania and Dr. Lauren Cohn as they provide an overview of how new and evolving treatment approaches in COPD incorporate treatable traits, which treatable traits are associated with type 2 inflammation, and the latest data from phase 3 clinical trials.

This is a non-CME event and does not qualify for CME or CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2024 conference sessions. This event is not an endorsement by CHEST and does not reflect the views or opinions of CHEST.

Speaker

Moderator: Nicola Hanania, MD, MS, FCCP
Baylor College of Medicine
Professor of Pulmonary Medicine
Houston, TX

Presenter: Lauren Cohn, MD, PhD
Yale School of Medicine
Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine)
New Haven, CT